These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
66 related articles for article (PubMed ID: 17872472)
21. Phenotypic modulation of intima and media smooth muscle cells in fatal cases of coronary artery lesion. Hao H; Gabbiani G; Camenzind E; Bacchetta M; Virmani R; Bochaton-Piallat ML Arterioscler Thromb Vasc Biol; 2006 Feb; 26(2):326-32. PubMed ID: 16339500 [TBL] [Abstract][Full Text] [Related]
22. Vertical inhibition of the mTORC1/mTORC2/PI3K pathway shows synergistic effects against melanoma in vitro and in vivo. Werzowa J; Koehrer S; Strommer S; Cejka D; Fuereder T; Zebedin E; Wacheck V J Invest Dermatol; 2011 Feb; 131(2):495-503. PubMed ID: 21048785 [TBL] [Abstract][Full Text] [Related]
23. Targeted deletion of PTEN in smooth muscle cells results in vascular remodeling and recruitment of progenitor cells through induction of stromal cell-derived factor-1alpha. Nemenoff RA; Simpson PA; Furgeson SB; Kaplan-Albuquerque N; Crossno J; Garl PJ; Cooper J; Weiser-Evans MC Circ Res; 2008 May; 102(9):1036-45. PubMed ID: 18340011 [TBL] [Abstract][Full Text] [Related]
24. Expression of lumican in thickened intima and smooth muscle cells in human coronary atherosclerosis. Onda M; Ishiwata T; Kawahara K; Wang R; Naito Z; Sugisaki Y Exp Mol Pathol; 2002 Apr; 72(2):142-9. PubMed ID: 11890723 [TBL] [Abstract][Full Text] [Related]
25. Blocking potassium channels: a new principle for treating restenosis? Olschewski A Cardiovasc Res; 2011 Feb; 89(2):255-7. PubMed ID: 21156820 [No Abstract] [Full Text] [Related]
26. 4E-binding protein phosphorylation and eukaryotic initiation factor-4E release are required for airway smooth muscle hypertrophy. Zhou L; Goldsmith AM; Bentley JK; Jia Y; Rodriguez ML; Abe MK; Fingar DC; Hershenson MB Am J Respir Cell Mol Biol; 2005 Aug; 33(2):195-202. PubMed ID: 15901615 [TBL] [Abstract][Full Text] [Related]
27. Vascular effects of cyclosporin A and acute rejection in canine heart transplantation. Bouchard D; Despatis MA; Buluran J; Cartier R Ann Thorac Surg; 1997 Nov; 64(5):1325-30. PubMed ID: 9386698 [TBL] [Abstract][Full Text] [Related]
28. Excessive intimal hyperplasia in human coronary arteries before intimal lipid depositions is the initiation of coronary atherosclerosis and constitutes a therapeutic target. Subbotin VM Drug Discov Today; 2016 Oct; 21(10):1578-1595. PubMed ID: 27265770 [TBL] [Abstract][Full Text] [Related]
29. Signal transduction pathways in androgen-dependent and -independent prostate cancer cell proliferation. Ghosh PM; Malik SN; Bedolla RG; Wang Y; Mikhailova M; Prihoda TJ; Troyer DA; Kreisberg JI Endocr Relat Cancer; 2005 Mar; 12(1):119-34. PubMed ID: 15788644 [TBL] [Abstract][Full Text] [Related]
30. Tanshinone IIA inhibits smooth muscle proliferation and intimal hyperplasia in the rat carotid balloon-injured model through inhibition of MAPK signaling pathway. Li X; Du JR; Yu Y; Bai B; Zheng XY J Ethnopharmacol; 2010 May; 129(2):273-9. PubMed ID: 20363310 [TBL] [Abstract][Full Text] [Related]
31. Activation of apoptosis signal-regulating kinase 1 in injured artery and its critical role in neointimal hyperplasia. Izumi Y; Kim S; Yoshiyama M; Izumiya Y; Yoshida K; Matsuzawa A; Koyama H; Nishizawa Y; Ichijo H; Yoshikawa J; Iwao H Circulation; 2003 Dec; 108(22):2812-8. PubMed ID: 14638553 [TBL] [Abstract][Full Text] [Related]
32. Enhanced expression of glucose transporter-1 in vascular smooth muscle cells via the Akt/tuberous sclerosis complex subunit 2 (TSC2)/mammalian target of rapamycin (mTOR)/ribosomal S6 protein kinase (S6K) pathway in experimental renal failure. Lin CY; Hsu SC; Lee HS; Lin SH; Tsai CS; Huang SM; Shih CC; Hsu YJ J Vasc Surg; 2013 Feb; 57(2):475-85. PubMed ID: 23265586 [TBL] [Abstract][Full Text] [Related]
33. Inhibition of intimal hyperplasia after stenting by over-expression of p15: a member of the INK4 family of cyclin-dependent kinase inhibitors. Segev A; Nili N; Qiang B; Osherov AB; Giordano FJ; Jaffe R; Gauldie J; Sparkes JD; Fraser AR; Ladouceur-Wodzak M; Butany J; Strauss BH J Mol Cell Cardiol; 2011 Mar; 50(3):417-25. PubMed ID: 21081134 [TBL] [Abstract][Full Text] [Related]
34. Short-term rapamycin for inhibition of neointima formation after balloon-mediated aortic injury in rats: is there a window of opportunity for systemic prophylaxis of restenosis? Jahnke T; Schäfer FK; Bolte H; Heuer G; Karbe U; Brossmann J; Brandt M; Heller M; Müller-Hülsbeck S J Endovasc Ther; 2005 Jun; 12(3):332-42. PubMed ID: 15943508 [TBL] [Abstract][Full Text] [Related]
35. The origin of intimal smooth muscle cells: are we on a steady road back to the past? De Geest B Cardiovasc Res; 2009 Jan; 81(1):7-8. PubMed ID: 19004811 [No Abstract] [Full Text] [Related]
36. Insulin and IGF-I stimulate the formation of the eukaryotic initiation factor 4F complex and protein synthesis in C2C12 myotubes independent of availability of external amino acids. Shen WH; Boyle DW; Wisniowski P; Bade A; Liechty EA J Endocrinol; 2005 May; 185(2):275-89. PubMed ID: 15845920 [TBL] [Abstract][Full Text] [Related]
37. TOR inhibitors and cardiac allograft vasculopathy: is inhibition of intimal thickening an adequate surrogate of benefit? Mehra MR; Uber PA J Heart Lung Transplant; 2003 May; 22(5):501-4. PubMed ID: 12742410 [No Abstract] [Full Text] [Related]